Washington: US biotech company Moderna announced on Wednesday that it has begun clinical trials of a booster dose of vaccine designed specifically to combat the Omicron variant of Covid-19.
The trials will involve a total of 600 adults — half of whom have already received two doses of Moderna’s vaccine at least six months ago, and half of whom have received two doses plus the previously authorized booster dose.
The booster specifically targeting Omicron will therefore be evaluated as both a third and a fourth dose.
Child sexual exploitation, the ugly reality no one wants to acknowledge, is deeply ingrained in…
Bad blood-related news comes from Balochistan almost every other day. And the attack on a…
Donald Trump's victory as the President of the United States has raised numerous new questions…
The International Cricket Council (ICC) finds itself entangled in an unwarranted controversy sparked by India's…
Leave a Comment